NCT01848067
- Conditions
- Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Clinical trial condition
Hormone-Resistant Prostate Cancer
Explore clinical trials studying Hormone-Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.
33 public trials
0 recruiting studies
Hormone-Resistant Prostate Cancer trial results
NCT03154190
- Conditions
- Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
- Locations
-
- Virginia K Crosson Cancer Center Fullerton, California, United States
NCT02184533
- Conditions
- Adenocarcinoma of the Prostate, Blood Protein Disorders, Cardiovascular Diseases, +26 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
NCT02499835
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +14 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
NCT02159950
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
NCT02012296
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Cancer Care Specialists of Central Illinois (Decatur) /Decatur Memorial Hospital Decatur, Illinois, United States
- NorthShore University Health System Evanston, Illinois, United States
- Wayne State University Karmanos Cancer Institute Detroit, Michigan, United States
NCT03122743
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
NCT01833208
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Western New York Urology Associates LLC-Harlem Cheektowaga, New York, United States
Completed
Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
NCT01812668
- Conditions
- Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Completed
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT01503229
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States